Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talmadge

Showing results (501-510 of 519) with videos related to

Pageof 52
Sort By:
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Respiratory Medicine|May 16, 2017
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseJulie Morisset, Eric Vittinghoff, Bo Young Lee, et al.
BMJ Open Respiratory Research|February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trialsLisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
International Immunopharmacology|December 12, 2023
Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung diseaseJill A Poole, Kathryn E Cole, Geoffrey M Thiele, et al.
Genomics|January 1, 1997
A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locusA Lanyi, B Li, S Li, et al.
Science (New York, N.Y.)|June 20, 1998
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIaJ D Eudy, M D Weston, S Yao, et al.
Transplantation|September 23, 2003
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantationSteven Z Pavletic, R Gregory Bociek, James M Foran, et al.
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal|July 27, 2014
Smoking-related idiopathic interstitial pneumoniaKevin R Flaherty, Charlene Fell, Marie-Christine Aubry, et al.
Pageof 52

Showing results (501-510 of 519) with videos related to

Sort By:
Pageof 52
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Respiratory Medicine|May 16, 2017
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseJulie Morisset, Eric Vittinghoff, Bo Young Lee, et al.
BMJ Open Respiratory Research|February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trialsLisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
International Immunopharmacology|December 12, 2023
Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung diseaseJill A Poole, Kathryn E Cole, Geoffrey M Thiele, et al.
Genomics|January 1, 1997
A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locusA Lanyi, B Li, S Li, et al.
Science (New York, N.Y.)|June 20, 1998
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIaJ D Eudy, M D Weston, S Yao, et al.
Transplantation|September 23, 2003
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantationSteven Z Pavletic, R Gregory Bociek, James M Foran, et al.
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal|July 27, 2014
Smoking-related idiopathic interstitial pneumoniaKevin R Flaherty, Charlene Fell, Marie-Christine Aubry, et al.
Pageof 52